XWELL, Inc. received a notice from Nasdaq on October 7, 2026, stating its common stock failed to maintain the required minimum closing bid price of $1.00 per share for 30 consecutive business days ending October 6, 2026. The company has an 180-day compliance period until April 5, 2027, to restore compliance by maintaining a closing price above $1.00 for ten consecutive trading days or by executing a reverse stock split at least ten business days before the deadline. Failure to regain compliance may result in delisting proceedings. XWELL operates as a digital health company focused on women's health and wellness.
